TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis



Status:Completed
Conditions:Osteoporosis, Osteoporosis
Therapuetic Areas:Rheumatology
Healthy:No
Age Range:45 - Any
Updated:4/21/2016
Start Date:April 2000
End Date:November 2003

Use our guide to learn which trials are right for you!

An 18-Month Double-Blind, Placebo-Controlled, Phase III, Trial With a 12-Month Interim Analysis of the Effect of Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis

This is an 18-month, double-blind, placebo-controlled, Phase III trial with a 12-month
interim analysis of the effect of ALX1-11, recombinant human parathyroid hormone (1-84)
(rhPTH [1-84]), on fracture incidence in women with postmenopausal osteoporosis, the TOP
study.

Parathyroid hormone (PTH), a polypeptide consisting of 84 amino acids that is synthesized
and secreted by the parathyroid glands, is a principal regulator of calcium homeostasis
through concerted action on kidney, intestine and bone. Parathyroid hormone exerts its
action on bone to release calcium into the extracellular fluid as a process of bone
remodeling and also to maintain the serum calcium concentration, but the exact mechanisms
are not fully understood. In some circumstances, PTH may exert an anabolic action on bone
and can stimulate osteoblast proliferation and mature osteoblast function. The net effect of
exogenous PTH administration on bone turnover depends on the pattern of delivery. A
continuous long-term infusion gives a net decrease in trabecular bone volume, whereas daily
single injections result in a net increase.

NPS Allelix Corp. is developing ALX1-11, recombinant human parathyroid hormone (1-84), for
the treatment of osteoporosis. ALX1-11 is identical to the endogenous intact 84 amino acid
human hormone and will be self-administered on a daily basis by subcutaneous (sc) injection.

Currently, there is no approved therapy for osteoporosis capable of stimulating the
formation of new bone of normal composition and structure. Most therapies in development are
anti-catabolic and only prevent further bone loss (e.g., estrogen replacement,
bisphosphonates, and calcitonins). ALX1-11 has the potential to stimulate new bone formation
in osteoporotic patients, thereby increasing bone mass and preventing fractures. Patients
with moderately or severely reduced bone density and a fracture would be expected to benefit
from treatment, thereby improving functional status and alleviating symptoms.

Inclusion Criteria:

- Women who are postmenopausal with at least one year since the last menstruation.

- Women who are 45-54 years of age with the following bone mineral density (BMD) and/or
vertebral fracture:

- BMD 3.0 standard deviations (SDs) or more below peak bone mass of young females
at the lumbar spine, femoral neck, or total hip; or

- BMD 2.5 SDs or more below peak bone mass of young females at the lumbar spine,
femoral neck or total hip with the presence of a vertebral fracture verified by
the central imaging organization before the patient is enrolled into the study.

- Women 55 or more years of age with the following BMD and/or vertebral fracture:

- BMD 2.5 SDs or more below peak bone mass of young females at the lumbar spine,
femoral neck or total hip; or

- BMD 2.0 SDs or more below peak bone mass of young females at the lumbar spine,
femoral neck or total hip with the presence of a vertebral fracture verified by
the central imaging organization before the patient is enrolled into the study.

- The following types of vertebral fractures should not be considered for patient
enrollment into this trial:

- Pathological fractures due to malignant disease or infection

- Fractures due to excessive trauma sufficient to cause a fracture in young
individuals with normal bone mass

- Women with the ability to self-administer a daily injection or have a designee who
will give the injections

- Women who are capable of understanding and giving written, voluntary informed consent
before the clinical trial screening visit

Exclusion Criteria:

A. Vertebral Deformity:

- Patient has 5 or more vertebral (thoracic and lumbar) deformities

- Patient has 2 or more lumbar vertebral deformities (L1 to L4)

- Severe lumbar scoliosis (>15 degrees) which precludes a reliable evaluation of the
dual x-ray absorptiometry (DXA)

B. DXA Imaging:

- Inability to have a DXA scan performed.

C. History or Concurrent Illness:

- Disorders of immunity

- Endocrine system

- Gastrointestinal system

- Kidney and collecting system

- Liver, biliary tract and pancreatic systems

- Musculoskeletal system

- Neoplasia

- Nervous system

- Vascular, respiratory and cardiac system

- Significant diseases or disorders are determined by history, physical exam or
laboratory screens and judged by the Principal Investigator to be significant.

D. Concurrent Medication:

Any patient who does not require medication washout (discontinuation) as specified below
may start study drug dosing after 2 weeks of stabilization treatment with calcium and
vitamin D3 supplements. All exceptions will be documented in the case report form (CRF).

- Patients cannot be enrolled into this clinical trial if they have received any of the
following therapies at any time:

- Any PTH or PTH analogs [e.g., rhPTH(1-84), PTH(1-34), PTHrP and analogs]

- Fluoride

- Strontium

- Patients must have been off the following agents for the specified times before
entering the screening phase of this clinical trial:

- Any investigational drug (30 days)

- Anabolic steroids or androgens (6 consecutive months)

- Active vitamin D3 metabolites and analogs(90 days)

- Systemic corticosteroids, more than 5 mg/day prednisone or a systemic
corticosteroid formulation equivalent to 5 mg/day prednisone (12 consecutive
months).

- A patient who has been enrolled in the study and needs to receive an acute bolus
of steroids (oral or injectable) for a self-limited illness may continue
treatment in the study if the following requirements are met:

1. Exposure to steroids is limited to no more than 30 consecutive days

2. The maximal dose of steroid (prednisone equivalent) is limited to no more
than 225 mg (7.5 mg each day for 30 days)

3. The illness is acute in nature and is not expected to recur during the
remaining treatment period of the study

- Daily inhaled corticosteroids unless dose is below 1200 mg/day of
beclomethasone.

- Bisphosphonates, including investigational bisphosphonates.

- Intravenous (IV) pamidronate. Patient must be receiving pamidronate specifically
to treat osteoporosis. Patient can have received only ONE IV dose of pamidronate
in the 12 months immediately preceding the screening visit.

- Cyclical etidronate. Exposure to cyclical etidronate must be less than or equal
to 6 months on a standard dose (e.g. 400 mg/day). Patient should not have
exposure to cyclical etidronate for 9 months prior to the screening visit.

- Phenytoin for seizure control. If the patient has received phenytoin within five
years of the screening visit, the patient is excluded from this study. The
patient may continue in the screening process if 15 years have passed since the
last dose of phenytoin at the time of the screening visit. If the phenytoin use
was between 5-15 years before the screening visit and the patient received
phenytoin for less than 2 months.

- Patients may be enrolled if they have been stabilized on the following therapy for
the specified amount of time:

* Thyroid hormone (<0.1 mg/day thyroxine) therapy for at least 6 months. * Stable
dosage of thiazide for at least 3 consecutive months.

- All patients must stop the following therapies at least 4 weeks prior to the
screening visit and remain off these therapies for the remainder of the clinical
trial. Screening laboratories must be performed after the washout is complete.
However, imaging studies (BMD, X-rays) may be performed prior to starting the
calcitonin, estrogen, and selective estrogen receptor modulation (SERM) washout.

- Calcitonin

- Estrogen replacement therapy by oral, transdermal or intramuscular
administration

- SERM drugs, e.g., tamoxifen, raloxifene, Evista

- Vaginal application of estrogen-containing creams unless the dose is conjugated
estrogen or estradiol* Cytostatics, e.g., azathioprine, recombinant human tumor
necrosis fusion (Fc) protein, monoclonal antibody against tumor necrosis factor
(e.g., remicade [infliximab])

- The drug class tetracyclines

- Medication known to affect the metabolism of bone (the Principal Investigator
should discuss this with the Project Medical Officer before the patient is
excluded from enrollment)

E. Miscellaneous Concurrent Medications:

- Methotrexate

- Intra-articular injections - Patients with chronic, active joint disease should be
excluded from this Phase III study. Patients may receive a maximum of one
intra-articular injection (ONE JOINT ONLY) every 6 months while participating in this
Phase III study. The dose of corticosteroid injected should not exceed the
anti-inflammatory equivalent dose of prednisone 40 mg suspension. The dose and volume
should be adjusted downward as appropriate to the size of the joint.

- Provera is an acceptable concomitant medication when used according to the label
instructions.

F. Laboratory Values and Physical Examination Findings:

- Serum calcium greater than 10.7 mg/dL (2.66 mmol/L). At screening, if the serum
calcium is abnormal, the patient may have the additional evaluation described below
ONCE:

1. Discontinue all oral calcium and vitamin D3 supplements.

2. Repeat a fasting serum calcium level two weeks later.

3. If the fasting serum calcium level is still abnormal, the patient is
discontinued from the study.

4. If the repeat fasting serum calcium is normal, the patient should have
supplemental calcium and vitamin D3 restarted at the time of study drug dosing,
without going through a two-week stabilization period.

- Serum creatinine > 1.5 mg/dL (132.6 mmol/L)

- Urinary calcium to creatinine ratio is greater than or equal to 1. At screening, if a
patient's urinary calcium to creatinine ratio is abnormal, the patient may have the
additional evaluation described below ONCE:

1. Discontinue all oral calcium and vitamin D3 supplements.

2. Repeat a fasting urine calcium to creatinine ratio two weeks later.

3. If the fasting urinary calcium to creatinine ratio is still abnormal, the
patient is discontinued from the study.

4. If the repeat fasting urinary calcium to creatinine ratio is normal, the patient
should have supplemental calcium and vitamin D3 restarted at the time of study
drug dosing, without going through a two-week stabilization period.

- Total serum alkaline phosphatase >130 U/L except as noted - Argentina (311 U/L);
Brazil (278 U/L); Mexico (159 U/L).

- Any other clinically significant abnormal value as judged by the investigator

- Body weight below 40 kg

G. Substance Abuse:

- Alcohol and/or drug abuse

H. Psychiatric Disease:

- Current or history of psychiatric disease that would interfere with the ability to
comply with the clinical trial protocol

I. Compliance:

- Suspected or confirmed poor compliance in completing clinical trial evaluations
and/or clinical trial required questionnaires
We found this trial at
108
sites
?
mi
from
New York, NY
Click here to add this to my saved trials
175 Cross Keys Rd.
Berlin, New Jersey 08009
856-753-7335
?
mi
from
Berlin, NJ
Click here to add this to my saved trials
1720 2nd Ave S
Birmingham, Alabama 35233
(205) 934-4011 
University of Alabama at Birmingham The University of Alabama at Birmingham (UAB) traces its roots...
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
75 Francis street
Boston, Massachusetts 02115
(617) 732-5500
Brigham and Women's Hosp Boston’s Brigham and Women’s Hospital (BWH) is an international leader in...
?
mi
from
Boston, MA
Click here to add this to my saved trials
5801 South Ellis Avenue
Chicago, Illinois 60637
 773.702.1234
University of Chicago One of the world's premier academic and research institutions, the University of...
?
mi
from
Chicago, IL
Click here to add this to my saved trials
1925 W. Mountain View Ave.
Longmont, Colorado 80501
303-776-8718
?
mi
from
Longmont, CO
Click here to add this to my saved trials
593 Eddy Street
Providence, Rhode Island 02903
401-444-4000
Rhode Island Hospital Founded in 1863, Rhode Island Hospital in Providence, RI, is a private,...
?
mi
from
Providence, RI
Click here to add this to my saved trials
8122 Datapoint Drive
San Antonio, Texas 78229
210-614-7483
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
1897 Palm Beach Lakes Boulevard
West Palm Beach, Florida 33409
561-689-0606
?
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
?
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Albuquerque, New Mexico 87108
?
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Anaheim, California 92801
?
mi
from
Anaheim, CA
Click here to add this to my saved trials
Anderson, South Carolina 29621
?
mi
from
Anderson, SC
Click here to add this to my saved trials
Atlanta, Georgia 30322
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
?
mi
from
Bangor, ME
Click here to add this to my saved trials
Bethesda, Maryland 20817
?
mi
from
Bethesda, MD
Click here to add this to my saved trials
Beverly Hills, California 90211
?
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Birmingham, Alabama 35205
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
Bismarck, North Dakota 58501
?
mi
from
Bismarck, ND
Click here to add this to my saved trials
Bloomington, Illinois 61704
?
mi
from
Bloomington, IL
Click here to add this to my saved trials
Boca Raton, Florida
?
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Boise, Idaho 83702
?
mi
from
Boise, ID
Click here to add this to my saved trials
Buenos Aires, BUE
?
mi
from
Buenos Aires,
Click here to add this to my saved trials
?
mi
from
Burlington, VT
Click here to add this to my saved trials
Charlotte, North Carolina 28210
?
mi
from
Charlotte, NC
Click here to add this to my saved trials
Chattanooga, Tennessee 37421
?
mi
from
Chattanooga, TN
Click here to add this to my saved trials
?
mi
from
Chicago, IL
Click here to add this to my saved trials
2049 E 100th St
Cleveland, Ohio 44106
(216) 444-2200
Cleveland Clinic Foundation The Cleveland Clinic (formally known as The Cleveland Clinic Foundation) is a...
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
Columbia, South Carolina 29204
?
mi
from
Columbia, SC
Click here to add this to my saved trials
Concord, California
?
mi
from
Concord, CA
Click here to add this to my saved trials
?
mi
from
Concord, NH
Click here to add this to my saved trials
?
mi
from
Cumberland, MD
Click here to add this to my saved trials
Dallas, Texas 75231
?
mi
from
Dallas, TX
Click here to add this to my saved trials
Denver, Colorado 80230
?
mi
from
Denver, CO
Click here to add this to my saved trials
?
mi
from
Des Moines, IA
Click here to add this to my saved trials
Detroit, Michigan 48236
?
mi
from
Detroit, MI
Click here to add this to my saved trials
Duncansville, Pennsylvania 16635
?
mi
from
Duncansville, PA
Click here to add this to my saved trials
2301 Erwin Rd
Durham, North Carolina 27710
919-684-8111
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
?
mi
from
Durham, NC
Click here to add this to my saved trials
Fall River, Massachusetts 02720
?
mi
from
Fall River, MA
Click here to add this to my saved trials
Fargo, North Dakota 58103
?
mi
from
Fargo, ND
Click here to add this to my saved trials
Fort Myers, Florida 33907
?
mi
from
Fort Myers, FL
Click here to add this to my saved trials
?
mi
from
Frederick, MD
Click here to add this to my saved trials
Grand Forks, North Dakota 58201
?
mi
from
Grand Forks, ND
Click here to add this to my saved trials
Greer, South Carolina
?
mi
from
Greer, SC
Click here to add this to my saved trials
?
mi
from
Hagerstown, MD
Click here to add this to my saved trials
Hamden, Connecticut 06518
?
mi
from
Hamden, CT
Click here to add this to my saved trials
?
mi
from
Hollywood, FL
Click here to add this to my saved trials
Honolulu, Hawaii 96814
?
mi
from
Honolulu, HI
Click here to add this to my saved trials
Houston, Texas 77024
?
mi
from
Houston, TX
Click here to add this to my saved trials
?
mi
from
Huntsville, AL
Click here to add this to my saved trials
Indianapolis, Indiana 46202
?
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Inverness, Florida 34452
?
mi
from
Inverness, FL
Click here to add this to my saved trials
Lake Worth, Florida 33461
?
mi
from
Lake Worth, FL
Click here to add this to my saved trials
Lakewood, Colorado 80337
?
mi
from
Lakewood, CO
Click here to add this to my saved trials
Las Vegas, Nevada 89106
?
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Loma Linda, California 92354
?
mi
from
Loma Linda, CA
Click here to add this to my saved trials
?
mi
from
Madison, WI
Click here to add this to my saved trials
Mayfield Village, Ohio 44143
?
mi
from
Mayfield Village, OH
Click here to add this to my saved trials
Medford, Oregon 97504
?
mi
from
Medford, OR
Click here to add this to my saved trials
?
mi
from
Miami, FL
Click here to add this to my saved trials
Midland, Texas 79705
?
mi
from
Midland, TX
Click here to add this to my saved trials
8701 W Watertown Plank Rd
Milwaukee, Wisconsin
(414) 955-8296
Medical College of Wisconsin The Medical College (MCW) of Wisconsin is a major national research...
?
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Mineola, New York 11501
?
mi
from
Mineola, NY
Click here to add this to my saved trials
Minot, North Dakota 58701
?
mi
from
Minot, ND
Click here to add this to my saved trials
New Orleans, Louisiana 70121
?
mi
from
New Orleans, LA
Click here to add this to my saved trials
New York, New York 10003
?
mi
from
New York, NY
Click here to add this to my saved trials
Newport News, Virginia 23606
?
mi
from
Newport News, VA
Click here to add this to my saved trials
?
mi
from
Oakland, CA
Click here to add this to my saved trials
Ocala, Florida 34471
?
mi
from
Ocala, FL
Click here to add this to my saved trials
Olive Branch, Mississippi 38654
?
mi
from
Olive Branch, MS
Click here to add this to my saved trials
Olympia, Washington 98502
?
mi
from
Olympia, WA
Click here to add this to my saved trials
Palm Beach Gardens, Florida 33410
?
mi
from
Palm Beach Gardens, FL
Click here to add this to my saved trials
Palm Desert, California 92260
?
mi
from
Palm Desert, CA
Click here to add this to my saved trials
Palm Harbor, Florida 34684
?
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
3801 Miranda Avenue
Palo Alto, California 94304
650-493-5000
VA Palo Alto Health Care System The VA Palo Alto Health Care System (VAPAHCS) consists...
?
mi
from
Palo Alto, CA
Click here to add this to my saved trials
1020 Walnut St
Philadelphia, Pennsylvania 19107
(215) 955-6000
Thomas Jefferson University We are dedicated to the health sciences and committed to educating professionals,...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phoenix, Arizona 85013
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
200 Lothrop St
Pittsburgh, Pennsylvania 15213
University of Pittsburgh Medical Center UPMC is one of the leading nonprofit health systems in...
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Providence, Rhode Island 02908
?
mi
from
Providence, RI
Click here to add this to my saved trials
Rancho Cucamonga, California 91730
?
mi
from
Rancho Cucamonga, CA
Click here to add this to my saved trials
Rapid City, South Dakota 57701
?
mi
from
Rapid City, SD
Click here to add this to my saved trials
Richmond, Virginia 23294
?
mi
from
Richmond, VA
Click here to add this to my saved trials
Richmond, Virginia 23298
?
mi
from
Richmond, VA
Click here to add this to my saved trials
Rochester, New York 14609
?
mi
from
Rochester, NY
Click here to add this to my saved trials
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
San Diego, California 92108
?
mi
from
San Diego, CA
Click here to add this to my saved trials
san Diego, California 92120
?
mi
from
san Diego, CA
Click here to add this to my saved trials
1001 Potrero Ave
San Francisco, California 94110
(415) 206-8000
San Francisco General Hospital San Francisco General Hospital and Trauma Center (SFGH) is an essential...
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
Sandy, Utah 84070
?
mi
from
Sandy, UT
Click here to add this to my saved trials
Santa Ana, California 92701
?
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Seattle, Washington 98104
?
mi
from
Seattle, WA
Click here to add this to my saved trials
Seattle, Washington 98105
?
mi
from
Seattle, WA
Click here to add this to my saved trials
Sioux Falls, South Dakota 57105
?
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
?
mi
from
South Miami, FL
Click here to add this to my saved trials
South Plainfield, New Jersey 07080
?
mi
from
South Plainfield, NJ
Click here to add this to my saved trials
Springfield, Missouri 65807
?
mi
from
Springfield, MO
Click here to add this to my saved trials
St. Petersburg, Florida 33702
?
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
Stony Brook, New York 11794
?
mi
from
Stony Brook, NY
Click here to add this to my saved trials
?
mi
from
Stuart, FL
Click here to add this to my saved trials
?
mi
from
Tulsa, OK
Click here to add this to my saved trials
3800 Reservoir Rd NW
Washington, District of Columbia 20007
(202) 687-7695
Georgetown University Medical Center Georgetown University Medical Center is committed to excellence in research, education...
?
mi
from
Washington,
Click here to add this to my saved trials